Effects of Kettlebell Swing Training Combined With Breathing Exercises on Respiratory Muscle Strength and Pulmonary Function in Overweight and Obese Young Adults
Kettlebell
1 other identifier
interventional
40
1 country
1
Brief Summary
Overweight and obesity are associated with impaired breathing mechanics, including reduced chest wall and diaphragmatic movement, decreased respiratory muscle strength and endurance, and inefficient breathing patterns. These changes may adversely affect pulmonary function, autonomic regulation, and physical capacity. This study aims to compare the effects of kettlebell swing exercise combined with breathing training versus breathing training alone in individuals with overweight or obesity. Outcomes will include respiratory muscle strength, pulmonary function, heart rate variability, and body composition. The findings may help determine whether adding kettlebell swing exercise to breathing training provides additional benefits for respiratory and cardiometabolic health in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 20, 2027
September 3, 2026
August 1, 2026
10 months
August 30, 2026
August 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Repiratory muscle strength
Respiratory muscle strength will be measured using a handheld manometer (MicroRPM). Participants will be instructed to perform a maximal inspiratory effort from residual volume to assess maximal inspiratory pressure (PImax) and a maximal expiratory effort from total lung capacity to assess maximal expiratory pressure (PEmax).
Before and after the 6 week intervention
Heart rate variability (HRV)
Time and frequency-domain heart rate variability (HRV) parameters will be measured using the SA-3000P analyzer.
Before and after the 6 week intervention
Pulmonary function test
Vital capacity (VC), expiratory reserve volume (ERV), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and the FEV₁/FVC ratio will be measured using a portable spirometer.
Before and after the 6 week intervention
Secondary Outcomes (1)
Body composition
Before and after the 6 week intervention
Study Arms (2)
Experimental group
EXPERIMENTALKettlebell swing training combined with breathing exercises
Control group
SHAM COMPARATORBreathing exercises
Interventions
Kettlebell swing training combined with breathing exercises, performed three times per week for 40 minutes per session over 6 weeks.
Breathing exercises performed three times per week for 20 minutes per session over 6 weeks.
Eligibility Criteria
You may qualify if:
- Male or female adults aged 18-25 years with a body mass index (BMI) of ≥23.0 kg/m².
- Individuals who are physically inactive or sedentary, defined as exercising fewer than 3 days per week or engaging in less than 150 minutes of exercise per week.
- Willingness to provide written informed consent to participate in the study.
You may not qualify if:
- Presence of bodily pain, particularly in the upper or lower extremities, with a Visual Analogue Scale (VAS) score of \>3/10.
- Musculoskeletal disorders, such as scoliosis.
- History of neurological disorders, including spinal cord injury, epilepsy, or stroke.
- History of respiratory or cardiovascular diseases, including hypertension, heart disease, emphysema, asthma, previous lung lobectomy, or lung cancer.
- History of chronic non-communicable diseases or other systemic disorders, including diabetes mellitus, kidney disease, liver disease, endocrine disorders, or immune system disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Allied Health Sciences, University of Phayao
Phayao, Changwat Phayao, 56000, Thailand
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Double (participant, outcomes assessor)
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor
Study Record Dates
First Submitted
August 30, 2026
First Posted
September 3, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
June 15, 2027
Study Completion (Estimated)
June 20, 2027
Last Updated
September 3, 2026
Record last verified: 2026-08